"Ozempic for Pets" Isn't Here Yet: What Las Vegas Owners Should Know About GLP-1 Weight-Loss Trials
Cat and dog versions of the popular human weight-loss drug class are in early testing, but nothing is approved for pets. Here is what the research actually shows and how to help an overweight pet right now.
Key takeaways
- GLP-1 medicines like the ones used in people are being tested in cats and dogs, but none are FDA approved for pets as of this writing.
- Two feline studies are furthest along: a twice-yearly implant from Okava Pharmaceuticals and a once-weekly injectable being studied with Cornell University.
- Giving a pet your own Ozempic, Mounjaro, or similar human prescription can trigger vomiting, dangerously low blood sugar, or worse, so it should never be attempted.
- Weight-loss medication for dogs has a history here already: the only drug ever cleared for canine obesity was pulled from the market years ago, which is part of why the new research matters.
Figures reflect published details of the MEOW-1 and Akston/Cornell feline trials and the discontinued canine drug Slentrol, current as of August 2026.
What's actually being tested
The buzz around a feline "Ozempic" traces back to two real but early-stage research programs, not a product sitting on pharmacy shelves. San Francisco-based Okava Pharmaceuticals is running a study called MEOW-1, which places a small under-the-skin implant in overweight cats. That implant, known as OKV-119, steadily releases exenatide, a GLP-1 receptor drug, and a single dose is designed to keep working for roughly six months before it needs to be replaced.
A separate effort pairs Massachusetts-based Akston Biosciences with Cornell University researchers. Their compound, given as a once-weekly shot rather than an implant, has enrolled about 70 client-owned cats for an eleven-week treatment window, with some animals continuing into an extension phase afterward. Both programs are still gathering weight and health data, and neither company has said publicly when, or if, it will ask the FDA for approval.
Why the excitement, and why the caution
Excess weight in cats and dogs is linked to diabetes, joint strain, and a shorter healthy lifespan, and veterinarians describe feline diabetes in particular as one of the fastest-growing conditions they see, often tied to that same obesity trend. That is why a drug class that helps people feel full sooner and eat less has researchers hopeful it could do something similar for pets.
But hope is not approval. As one CityVet veterinarian put it plainly, there is no magic shot for pet obesity, at least not yet. The current trials are measuring safety as much as results, and both are years away from a possible commercial product even under an optimistic timeline.
Never share your own prescription with a pet
Because human GLP-1 drugs such as semaglutide and tirzepatide are dosed for a person's body weight and physiology, giving even a small fraction of a human dose to a cat or dog is not a safe shortcut. Veterinary sources warn it can bring on severe, persistent vomiting and diarrhea, pancreatitis, dangerously low blood sugar, or organ strain, and dosing an animal correctly at home simply isn't possible with a product built for people.
Worth remembering: dogs already have a cautionary tale here. Dirlotapide, sold as Slentrol, was the only medication ever approved in the United States specifically for canine weight loss, cleared back in 2007. It was pulled from the market a few years later. Any new pet obesity drug will need to clear that same high bar for long-term safety before it reaches a clinic near you.
What to do for your pet in the meantime
Until a GLP-1 option for animals clears trials and earns approval, the tools that actually move the needle on pet weight are the unglamorous ones: measured portions, fewer table scraps, a vet-guided prescription diet if needed, and regular movement suited to Las Vegas's climate, such as early-morning or after-dark walks instead of midday heat.
A weigh-in and body condition check at a routine visit is still the simplest way to catch creeping weight gain before it becomes a bigger problem. If it has been a while since your cat or dog was seen, scheduling a wellness exam is a good next step, not a diagnosis, just a chance to get a clear baseline and a plan.
5 things to do for an overweight pet right now, no prescription needed
None of this requires waiting on a future drug approval. These are the steps a vet team will usually start with today.
- Do a hands-on rib check: You should be able to feel ribs under a thin layer of fat without pressing hard; if you can't, that's worth mentioning at your next visit.
- Measure every meal: Free-feeding or eyeballing a scoop is one of the most common ways portions creep up over months without anyone noticing.
- Cap the treats: Treats and scraps should stay under roughly 10 percent of daily calories; ask your vet team for a target that fits your pet's size.
- Swap heat-of-day walks for cooler hours: Early morning or after sunset keeps exercise safe and consistent instead of skipped on the hottest afternoons.
- Ask about a therapeutic diet: Prescription weight-management foods are formulated to keep a pet satisfied on fewer calories, unlike simply feeding less of a regular diet.
- Schedule a weigh-in: A quarterly check-in tracks trends early, before a few extra pounds turn into a harder-to-reverse habit.
Frequently Asked Questions
Is there an approved "Ozempic for pets" I can ask my vet for?
Not yet. As of August 2026, cats and dogs have no cleared GLP-1 medication for shedding pounds; the furthest-along programs are still in clinical trials.
Can I give my dog or cat my own semaglutide or tirzepatide?
No. These medications are dosed for human physiology and have been linked to serious reactions in animals, including vomiting, diarrhea, pancreatitis, and dangerously low blood sugar. Any weight-management medication for a pet should come from your veterinarian.
When might a pet GLP-1 drug actually be available?
Neither of the current feline trials has announced an approval timeline, and both are still collecting safety and effectiveness data, so a commercial product is not expected soon.
What can I do for my overweight pet today?
Measured portions, limited treats, vet-guided exercise timing, and a wellness visit to check body condition remain the most reliable tools while research continues.
Sources
- GLP-1 in Pets — CityVet
- Breakthrough GLP-1 implant promises major weight loss benefits for pets — Fox News
- GLP-1 Pets: Pet Weight Loss Drugs, Trials & Pipeline — GLP1Pets.com